Zusammenfassung
Transfusionsreaktionen können nach verschiedenen Gesichtspunkten klassifiziert werden: Es könnten etwa unter Berücksichtigung des zeitlichen Ablaufs Sofortreaktionen von verzögerten Transfusionsreaktionen abgegrenzt werden. Der Einfachheit einer solchen Klassifikation stünde als Nachteil gegenüber, dass sehr heterogene Reaktionen zusammengefasst und ätiologisch eng verwandte Reaktionen getrennt werden müßten. Eine Klassifikation kann aber auch aus der zugrundeliegenden Ätiologie abgeleitet werden, dabei könnten immunologisch induzierte Transfusionsreaktionen von anderen Transfusionswirkungen unterschieden werden.
Die Beschreibung der Transfusionsreaktionen in diesem Kapitel teilt Transfusionsreaktionen daher anhand der beobachteten Symptome ein und berücksichtigt ätiologische Gesichtpunkte, soweit unsere heutigen Kenntnisse dies erlauben (Tab. 37.1). In der Darstellung dieses Kapitels, dessen Gliederung der Klassifikation einer internationalen Arbeitsgruppe des European Hemovigilance Network folgt [32], werden diejenigen Bezeichnungen für einzelne Reaktionen und Erkrankungen verwendet, die sich auch in der internationalen Literatur eingebürgert haben.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Alyea EP, Anderson KC (2007) Transfusion-associated graft-vs.-host disease. In: Popovsky MA (ed) Transfusion Reactions. AABB Press, Bethesda, pp 229–250
Anolik JH, Blumberg N, Snider J, Francis CW (2001) Posttransfusion purpura secondary to an alloantibody reactive with HPA-5a (Br(b)). Transfusion 41:633–636
Asai T, Inaba S, Ohto H, Osada K, Suzuki G, Takahashi K, Tadokoro K, Minami M (2000) Guidelines for irradiation of blood and blood com-ponents to prevent post-transfusion graft-vs.-host disease in Japan. Transfus Med 10:315–320
Ballem PJ, Buskard NA, Decary F, Doubroff P (1987) Post-transfusion purpura secondary to passive transfer of anti-Pl(A1) by blood transfusion. Br J Haematol 66:113–114
BCSH Blood Transfusion Task Force (1996) Guidelines on gamma irradiation of blood components for the prevention of transfusion-associated graft-versus-host disease. Transfus Med 6:261–271
Beauregard P, Blajchman MA (1994) Hemolytic and pseudo-hemolytic transfusion reactions: an overview of the hemolytic transfusion reactions and the clinical conditions that mimic them. Transfus Med Rev 8:184–199
Bierling P, Godeau B, Fromont P, Bettaieb A, Debili N, El-Kassar N, Rouby JJ, Vainchenker W, Duedari N (1995) Posttransfusion purpura-like syndrome associated with CD36 (Nak(a)) isoimmunization. Transfusion 35:777–782
Bolan CD, Childs RW, Procter JL, Barrett AJ, Leitman SF (2001) Massive immune haemolysis after allogeneic peripheral blood stem cell transplantation with minor ABO incompatibility. Br J Haematol 112:787–795
Brecher ME, Leger RM, Linden JV, Roseff SD (2005) Technical manual. American Association of Blood Banks, Bethesda
Brunner-Bollinger S, Kiefel V, Horber FF, Nydegger UE, Berchtold P (1997) Antibody studies in a patient with acute thrombocytopenia following infusion of plasma containing anti-Pl(A1). Am J Hematol 56:119–121
Bundesärztekammer, Paul-Ehrlich-Institut (2005) Richtlinien zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten gemäß §§ 12 und 18 des Transfusionsgesetzes (TFG) (Novelle 2005) vom 19. September 2005. Bundesanzeiger 57:1–36
Burks AW, Sampson HA, Buckley RH (1986) Analphylactic reactions after gamma globulin administration in patients with hypogammaglobulinemia. Detection of IgE antibodies to IgA. N Engl J Med 314:560– 564
Butler J, Parker D, Pillai R, Shale DJ, Rocker GM (1991) Systemic release of neutrophil elastase and tumour necrosis factor alpha following ABO incompatible blood transfusion. Br J Haematol 79:525–526
Bux J, Becker F, Seeger W, Kilpatrick D, Chapman J, Waters A (1996) Transfusion-related acute lung injury due to anti-HLA-A2-specific antibodies in recipient and NB1-specific antibodies in donor blood. Br J Haematol 93:707–713
Capon SM, Goldfinger D (1995) Acute hemolytic transfusion reaction, a paradigm of the systemic inflammatory response: new insights into pathophysiology and treatment. Transfusion 35:513–520
Cario H, Janka-Schaub G, Janssen G, Jarisch A, Strauss G, Kohne E (2007) Recent developments in iron chelation therapy. Klin Pädiatr 219:158–165
Chapman CE, Williamson LM (2008) National Blood Service TRALI reduction policies:implementation and effect. Transfusion Medicine and Hemotherapy 35:93–96
Christie DJ, Pulkrabek S, Putnam JL, Slatkoff ML, Pischel KD (1991) Posttransfusion purpura due to an alloantibody reactive with glycoprotein Ia/IIa (anti-HPA-5b). Blood 77:2785–2789
Conway LT, Scott EP (1984) Acute hemolytic transfusion reaction due to ABO incompatible plateletapheresis concentrate. Transfusion 24:413–414
Croucher BEE, Crookston MC, Crookston JH (1967) Delayed haemolytic transfusion reaction simulating auto-immune haemolytic anemia. Vox Sang 12:32–42
Davenport RD (1996) Cytokines as intercellular signals in hemolytic transfusion reactions. Biological Signals 5:240–245
Davenport RD, Strieter RM, Standiford TJ, Kunkel SL (1990) Interleukin-8 production in red blood cell incompatibility. Blood 76: 2439–2442
Davenport RD, Kunkel SL (1994) Cytokine roles in hemolytic and nonhemolytic transfusion reactions. Transfus Med Rev 8:157–168
Davenport RD, Strieter RM, Kunkel SL (1991) Red cell ABO incompatibility and production of tumour necrosis factor-alpha. Br J Haematol 78:540–544
Davenport RD, Polak TJ, Kunkel SL (1994) White cell-associated procoagulant activity induced by ABO incompatibility. Transfusion 34:943–949
Davenport RD, Burdick MD, Strieter RM, Kunkel SL (1994) In vitro production of interleukin-1 receptor antagonist in IgG-mediated red cell incompatibility. Transfusion 34:297–303
de Rie MA, van der Plas-van Dalen CM, Engelfriet CP, von dem Borne AE (1985) The serology of febrile transfusion reactions. Vox Sang 49:126–134
Decary F, Ferner P, Giavedoni L, Hartman A, Howie R, Kalovsky E, Laschinger C, Malette M, Martyres A, Mervart H, Naylor DH, St. Rose JEM, Shepherd FA, Tibensky D (1984) An investigation of nonhemolytic transfusion reactions. Vox Sang 46:277–285
Dieleman LA, Brand A, Claas FHJ, van de Keur C, Witvliet M, Giphart MJ (1989) Acquired Zw(a) antigen on Zw(a) negative platelets demonstrated by Western blotting. Br J Haematol 72:539–542
Dinarello CA, Cannon JG, Wolff SM, Bernheim HA, Beutler B, Cerami A, Figari IS, Palladino MA Jr, O’Connor JV (1986) Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med 163:1433–1450
Eastlund T, McGrath PC, Britten A, Propp R (1989) Fatal pulmonary transfusion reaction to plasma containing donor HLA antibody. Vox Sang 57:63–66
EHN (European Hemovigilance Network) working group on definitions of ATEs (2004) Adverse Transfusion Events (ATEs). Electronic document: Definitions_of_ATEs_Zurich. http://www.ehn-org.net
Engelfriet CP, Reesink HW, Brand A, Palfi M, Popovsky MA, Martin-Vega C, Ribera A, Rouger P, Goldman M, Freedman J, Lucas G, Navarette C, Neppert J, von Witzleben-Schürholz E, Lin M, Zupanska B (2001) International forum. Transfusion-related acute lung injury (TRALI). Vox Sang 81:269–283
Felix CA, Davey RJ (1987) Massive acute hemolysis secondary to Clostridium perfringens sepsis in a recently transfused oncology patient with multiple alloantibodies. Medical and Pediatric Oncology 15:42–44
Ferrara JL, Yanik G (2005) Acute graft versus host disease:pathophysiology, risk factors, and prevention strategies. Clin Adv Hematol Oncol 3:415–449
Friedman HD, Noonan M (1996) Acute gram-negative urosepsis mimicking an acute hemolytic transfusion reaction. Transfusion 36:460–462
Gabutti V, Borgna-Pignatti C (1994) Clinical manifestations and therapy of transfusional haemosiderosis. Baillieres Clin Haematol 7: 919–940
Gajic O, Gropper MA, Hubmayr RD (2006) Pulmonary edema after transfusion:how to differentiate transfusion-associated circulatory overload from transfusion-related acute lung injury. Crit Care Med 34:S109–S113
Gerstner JB, Smith MJ, Davis KD, Cimo PL, Aster RH (1979) Posttransfusion purpura:therapeutic failure of Pl(A1)-negative platelet transfusion. Am J Hematol 6:71–75
Giardina PJ, Grady RW (1995) Chelation therapy in beta-thalassemia: the benefits and limitations of desferrioxamine. Semin Hematol 32:304–312
Hamblin TJ, Naorose Abidi SM, Nee PA, Copplestone A, Mufti GJ, Oscier DG (1985) Successful treatment of post-transfusion purpura with high dose immunoglobulins after lack of response to plasma exchange. Vox Sang 49:164–167
Harrington WJ, Minnich V, Hollingsworth JW, Moore CV (1951) Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura. J Lab Clin Med 38:1–10
Heddle NM, Klama L, Singer J, Richards C, Fedak P, Walker I, Kelton JG (1994) The role of the plasma from platelet concentrates in transfusion reactions. N Engl J Med 331:625–628
Holland PV, Wallerstein RO (1968) Delayed hemolytic transfusion reaction with acute renal failure. JAMA 204:1007–1008
ISBT Working Party on Granulocyte Immunobiology (2009) Recommendations of the ISBT Working Party on Granulocyte Immunobiology for leukocyte antibody screening in the investigation and prevention of antibody-mediated transfusion-related acute lung injury. Vox Sang 96:266–269
Issitt PD, Combs MR, Bumgarner DJ, Allen J, Kirkland A, Melroy-Carawan H (1996) Studies of antibodies in the sera of patients who have made red cell autoantibodies. Transfusion 36:481–486
Jenner PW, Holland PV (1996) Diagnosis and management of transfusion reactions. In: Petz LD, Swisher SN, Kleinmann S, Spence RK (eds) Clinical practice of transfusion medicine. Churchill Livingstone, New York, pp 905–929
Kaltwasser JP (1996) Eisenstoffwechsel. In: Mueller-Eckhardt C (ed) Transfusionsmedizin. Grundlagen, Therapie, Methodik. Springer, Berlin, S 113–124
Kaufman J, Spinelli SL, Schultz E, Blumberg N, Phipps RP (2007) Release of biologically active CD154 during collection and storage of platelet concentrates prepared for transfusion. J Thromb Haemost 5:788–796
Keller-Stanislawski B, Lohmann A, Günay S, Heiden M, Funk MB (2009) The German Haemovigilance System-reports of serious adverse transfusion reactions between 1997 and 2007. Transfus Med 16:340–349
Kernoff PBA, Durant IJ, Rizza CR, Wright FW (1972) Severe allergic pulmonary oedema after plasma transfusion. Br J Haematol 23:777–781
Kiefel V (1992) The MAIPA assay and its applications in immunohematology. Transfus Med 2:181–188
Kiefel V (2008) Reactions induced by platelet transfusions. Transfusion Medicine and Hemotherapy 35:354–358
Kiefel V, Santoso S, Weisheit M, Mueller-Eckhardt C (1987) Monoclonal antibody-specific immobilization of platelet antigens (MAIPA):a new tool for the identification of platelet reactive antibodies. Blood 70:1722–1726
Kiefel V, Schönberner-Richter I, Schilf K (2005) Anti-HPA-1a in a case of post-transfusion purpura:binding to antigen-negative platelets detected by adsorption/elution. Transfus Med 15:243–247
King KE, Shirey RS, Lankiewicz MW, Young-Ramsaran J, Ness PM (1997) Delayed hemolytic transfusion reactions in sickle cell disease:simultaneous destruction of recipients’ red cells. Transfusion 37:376–381
Kleinman S, Caulfield T, Chan P, Davenport R, McFarland J, McPhedran S, Meade M, Morrison D, Pinsent T, Robillard P, Slinger P (2004) Toward an understanding of transfusion-related acute lung injury:statement of a consensus panel. Transfusion 44:1774–1789
Kopko PM, Holland PV (1999) Transfusion-related acute lung injury. Br J Haematol 105:322–329
Kopko PM, Paglieroni TG, Popovsky MA, Muto KN, MacKenzie MR, Holland PV (2003) TRALI:correlation of antigen-antibody and monocyte activation in donor-recipient pairs. Transfusion 43:177–184
Kroll H, Kiefel V, Mueller-Eckhardt C (1993) Posttransfusionelle Purpura: Klinische und immunologische Untersuchungen bei 38 Patientinnen. Infusionsther Transfusionsmed 20:198–204
Larsson LG, Welsh VJ, Ladd DJ (2000) Acute intravascular hemolysis secondary to out-of-group platelet transfusion. Transfusion 40:902–906
Laschinger C, Shepherd FA, Naylor DH (1984) Anti-IgA-mediated transfusion reactions in Canada. Can Med Assoc J 130:141–144
Leo A, Mytilineos J, Voso MT, Weber-Nordt R, Liebisch P, Lensing C, Schraven B (2000) Passenger lymphocyte syndrome with severe hemolytic anemia due to an anti-Jk(a) after allogeneic PBPC transplantation. Transfusion 40:632–636
Li G, Daniels CE, Kojicic M, Krpata T, Wilson GA, Winters JL, Moore SB, Gajic O (2009) The accuracy of natriuretic peptides (brain natriuretic peptide and N-terminal pro-brain natriuretic) in the differentiation between transfusion-related acute lung injury and transfusion-related circulatory overload in the critically ill. Transfusion 49:13–20
Linden JV (1999) Errors in transfusion medicine. Scope of the problem. Arch Path Lab Med 123:563–565
Linden JV, Paul B, Dressler KP (1992) A report of 104 transfusion errors in New York State. Transfusion 32:601–606
Linden JV, Kaplan HS, Murphy MT (1997) Fatal air embolism due to perioperative blood recovery. Anesth Analg 84:422–426
Lögdberg LE, Vikulina T, Zimring JC, Hillyer CD (2009) Animal models of transfusion-related acute lung injury. Transfus Med Rev 23:13–24
Lucas G, Rogers S, Evans R, Hambley H, Win N (2000) Transfusion-related acute lung injury associated with interdonor incompatibility for the neutrophil-specific antigen HNA-1a. Vox Sang 79:112–115
Mair B, Benson K (1998) Evaluation of changes in hemoglobin levels associated with ABO-incompatible plasma in apheresis platelets. Transfusion 38:51–55
McManigal S, Sims KL (1999) Intravascular hemolysis secondary to ABO incompatible platelet products. An underrecognized transfusion reaction. Am J Clin Pathol 111:202–206
McMilin KD, Johnson RL (1993) HLA homozygosity and the risk of related-donor transfusion-associated graft-versus-host-disease. Transfus Med Rev 7:37–41
Mollison PL (1983) Blood transfusion in clinical medicine. Blackwell, Oxford
Mollison PL, Engelfriet CP, Contreras M (1993) Blood transfusion in clinical medicine. Blackwell, Oxford
Mollison PL, Engelfriet CP, Contreras M (1997) Blood transfusion in clinical medicine. Blackwell, Oxford
Mori S, Matsushita H, Ozaki K, Ishida A, Tokuhira M, Nakajima H, Kizaki M, Sugiura H, Kikuchi A, Handa M, Kawai Y, Yamamori S, Ikeda Y (1995) Spontaneous resolution of transfusion-associated graft-versus-host disease. Transfusion 35:431–435
Morrison FS, Mollison PL (1966) Post-transfusion purpura. N Engl J Med 275:243–248
Mueller-Eckhardt C (1986) Post-transfusion purpura. Br J Haematol 64:419–424
Mueller-Eckhardt C, Kiefel V (1988) High-dose IgG for post-transfusion purpura – revisited. Blut 57:163–167
Mueller-Eckhardt C, Küenzlen E, Thilo-Körner D, Pralle H (1983) Highdose intravenous immunoglobulin for post-transfusion purpura (letter). N Engl J Med 308:287
Mueller-Eckhardt C, Kiefel V, Mueller-Eckhardt G, Bambauer R, Baur J, Behringhoff B, Deuss U, Heinrich D, Klein HO, Lechner K, Maas D, Panzer S, Sprenger R, Stählin H, Vahrson H (1986) Posttransfusion purpura. A survey of 13 cases. Klin Wochenschr 64:1198–1203
Mueller-Eckhardt C, Kroll H, Kiefel V (1991) Posttransfusion purpura. In: Kaplan-Gouet C, Schlegel N, Salmon C, McGregor J (eds) Platelet immunology:fundamental and clinical aspects. Proceedings of the first European Symposium on platelet immunology held in Paris, Palais du Luxembourg, March 1–2, 1990. John Libbey Eurotext, Paris, pp 249–255
Muylle L, Wouters E, De Bock R, Peetermans ME (1992) Reactions to platelet transfusion:the effect of the storage time of the concentrate. Transfus Med 2:289–293
Ness PM, Shirey RS, Thoman SK, Buck SA (1990) The differentiation of delayed serologic and delayed hemolytic transfusion reactions:incidence, long-term serologic findings, and clinical significance. Transfusion 30:688–693
Ness PM, Shirey RS, Weinstein MH, King KE (2001) An animal model for delayed hemolytic transfusion reactions. Transfus Med Rev 15:305–317
Nishimura M, Hashimoto S, Takanashi M, Okazaki H, Satake M, Nakajima K (2007) Role of anti-human leucocyte antigen class II alloantibody and monocytes in development of transfusion-related acute lung injury. Transfus Med 17:129–134
Nydegger UE, Kazatchkine MD (1983) The role of complement in immune clearance of blood cells. Springer Semin Immunopathol 6:373–398
Ohto H, Anderson KC (1996) Posttransfusion graft-versus-host disease in Japanese newborns. Transfusion 36:117–123
Perkins HA, Payne R, Ferguson J, Wood M (1966) Nonhemolytic febrile transfusion reactions. Quantitative effects of blood components with emphasis on isoantigenic incompatibility of leukocytes. Vox Sang 11:578–600
Petz LD, Calhoun L, Shulman IA, Johnson C, Herron RM (1997) The sickle cell hemolytic reaction syndrome. Transfusion 37:382–392
Pietersz RNI, Engelfriet CP, Reesink HW, Davis KG, Lown J, Thomson A, Turek P, Dickmeiss E, Krusius T, Matilainen J, Kretschmer V, Karger R, Reinhardt P, Wiesneth M, Schrezenmeier H, Seifried E, Rebulla P, Greppi N, Riccardi D, Morelati F, Uchikawa M, Tsino NH, Takahashi K, Novotny VMJ, Brand A, Solheim BG, Zupanska B, Lozano M, Mazzara R, Knutson F, Norda R, Knutson F, Norda R, Frey BM, MacLennan S, Heal JM, Blumberg N (2005) Transfusion of apheresis platelets and ABO groups. Vox Sang 88:207–221
Pineda AA, Taswell HF (1975) Transfusion reactions with Anti-IgA antibodies: report of four cases and review of the literature. Transfusion 15:10–15
Poole J, Daniels G (2007) Blood group antibodies and their significance in transfusion medicine. Transfus Med Rev 21:58–71
Popovsky MA (2004) Transfusion and the lung:circulatory overload and acute lung injury. Vox Sang 87 (Suppl 2):62–65
Popovsky MA (2007) Circulatory overload. In: Popovsky MA (ed) Transfusion Reactions. AABB Press, Bethesda, pp 331–339
Popovsky MA, Moore SB (1985) Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 25:573–577
Popovsky MA, Abel MD, Moore SB (1983) Transfusion-related acute lung injury associated with passive transfer of antileukocyte antibodies. Am Rev Respir Dis 128:185–189
Popovsky MA, Audet AM, Andrzejewski C Jr (1996) Transfusion-associated circulatory overload in orthopedic surgery patients: a multi-institutional study. Immunohematol 12:87–89
Prince M, Szer J, van der Weyden MB, Pedersen JS, Holdsworth RF, Whyte G (1991) Transfusion associated graft-versus-host disease after cardiac surgery:response to antithymocyte-globulin and corticosteroid therapy. Aust NZJ Med 21:43–46
Ramsey G (1991) Red cell antibodies arising from solid organ transplants. Transfusion 31:76–86
Redman M, Regan F, Contreras M (1996) A prospective study of the incidence of red cell allo-immunization following transfusion. Vox Sang 71:216–220
Reil A, Keller-Stanislawski B, Günay S, Bux J (2008) Specificities of leucocyte alloantibodies in transfusion-related acute lung injury and results of leucocyte antibody screening of blood donors. Vox Sang 95:313–317
Rühl H, Bein G, Sachs UJ (2009) Transfusion-associated graft-versushost disease. Transfus Med Rev 23:62–71
Sachs UJ, Hattar K, Weissmann N, Bohle RM, Weiss T, Sibelius U, Bux J (2006) Antibody-induced neutrophil activation as a trigger for transfusion-related acute lung injury in an ex vivo rat lung model. Blood 107:1217–1219
Salama A, Mueller-Eckhardt C (1984) Delayed hemolytic transfusion reactions. Evidence for complement activation involving allogeneic and autologous red cells. Transfusion 24:188–193
Salama A, Schwind P, Schonhage K, Genth R, Cotting C, Hustinx H, Krieg R, Nydegger U, Aebischer I (2001) Rapid detection of antibodies to immunoglobulin A molecules by using the particle gel immunoassay. Vox Sang 81:45–48
Salmon JP, Michaux S, Hermanne JP, Baudoux E, Gerard C, Sontag-Thull D, Fillet G, Beguin Y (1999) Delayed massive immune hemolysis mediated by minor ABO incompatibility after allogeneic peripheral blood progenitor cell transplantation. Transfusion 39:824–827
Sandler SG, Eckrich R, Malamut D, Mallory D (1994) Hemagglutination assays for the diagnosis and prevention of IgA anaphylactic transfusion reactions. Blood 84:2031–2035
Sandler SG, Mallory D, Malamut D, Eckrich R (1995) IgA anaphylactic transfusion reactions. Transfus Med Rev 9:1–8
Sazama K (1990) Reports of 355 transfusion-associated deaths:1976 through 1985. Transfusion 30:583–590
Schroeder ML (2002) Transfusion-associated graft-versus-host disease. Br J Haematol 117:275–287
Scott EP, Moilan-Bergeland J, Dalmasso AP (1988) Posttransfusion thrombocytopenia associated with passive transfusion of a plateletspecific antibody. Transfusion 28:73–76
Seeger W, Schneider U, Kreusler B, von Witzleben E, Walmrath D, Grimminger F, Neppert J (1990) Reproduction of transfusion-related acute lung injury in an ex vivo lung model. Blood 76:1438–1444
Shimada E, Tadokoro K, Watanabe Y, Ikeda K, Niihara H, Maeda I, Isa K, Moriya S, Ashida T, Mitsunaga S, Nakajima K, Juji T (2002) Anaphylactic transfusion reactions in haptoglobin-deficient patients with IgE and IgG haptoglobin antibodies. Transfusion 42:766–773
Shulman NR, Jordan JV (1987) Platelet immunology. In: Colman RW, Hirsh J, Marder VJ, Salzman EW (eds) Hemostasis and thrombosis. Basic principles and practice. Lippincott, Philadelphia, pp 452–529
Shulman NR, Aster RH, Leithner A, Hiller MC (1961) Immunoreactions involving platelets. V. Post-transfusion purpura due to a complementfixing antibody against a genetically controlled platelet antigen. A proposed mechanism for thrombocytopenia and its relevance in »autoimmunity«. J Clin Invest 40:1597–1620
Silliman CC (1999) Transfusion-related acute lung injury. Transfus Med Rev 13:177–186
Sloand EM, Fox SM, Banks SM, Klein HG (1990) Preparation of IgA-deficient platelets. Transfusion 30:322–326
Silliman CC, Paterson AJ, Dickey WO, Stroncek DF, Popovsky MA, Caldwell SA, Ambruso DR (1997) The association of biologically active lipids with the development of transfusion-related acute lung injury: a retrospective study. Transfusion 37:719–726
Spector JI, Crosby WH (1975) Coagulation studies during experimental hemoglobinemia in humans. J Appl Physiol 38:195–198
Stack G, Judge JV, Snyder EL (1996) Febrile and nonimmune transfusion reactions. In: Rossi EC, Simon TL, Moss GS, Gould SA (eds) Principles of transfusion medicine. Williams & Wilkins, Baltimore, pp 773–784
Stainsby D, Jones H, Asher D, Atterbury C, Boncinelli A, Brant L, Chapman CE, Davison K, Gerrard R, Gray A, Knowles S, Love EM, Milkins C, McClelland DB, Norfolk DR, Soldan K, Taylor C, Revill J, Williamson LM, Cohen H (2006) Serious hazards of transfusion:a decade of hemovigilance in the UK. Transfus Med Rev 20:273–282
Stricker RB, Lewis BH, Corash L, Shuman MA (1987) Posttransfusion purpura associated with an autoantibody directed against a previously undefined platelet antigen. Blood 69:1458–1463
Taaning E, Tonnesen F (1999) Pan-reactive platelet antibodies in posttransfusion purpura. Vox Sang 76:120–123
Tobian AA, Sokoll LJ, Tisch DJ, Ness PM, Shan H (2008) N-terminal probrain natriuretic peptide is a useful diagnostic marker for transfusionassociated circulatory overload. Transfusion 48:1143–1150
Utter GH, Reed WF, Lee TH, Busch MP (2007) Transfusion-associated microchimerism. Vox Sang 93:188–195
Valbonesi M, De Luigi MC, Lercari G, Florio G, Bruni R, Van Lint MT, Occhini D (2000) Acute intravascular hemolysis in two patients transfused with dry-platelet units obtained from the same ABO incompatible donor. Int J Artif Organs 23:642–646
Vamvakas EC, Pineda AA, Reisner R, Santrach PJ, Moore SB (1995) The differentiation of delayed hemolytic and delayed serologic transfusion reactions:incidence and predictors of hemolysis. Transfusion 35:26–32
Vichinsky E (2008) Clinical application of deferasirox:practical patient management. Am J Hematol 83:398–402
Vichinsky EP, Earles A, Johnson RA, Hoag MS, Williams A, Lubin B (1990) Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 322:1617–1621
Vo TD, Cowles J, Heal JM, Blumberg N (2001) Platelet washing to prevent recurrent febrile reactions to leucocyte-reduced transfusions. Transfus Med 11:45–47
Von Zabern I, Ehlers M, Grunwald U, Mauermann K, Greinacher A (1998) Release of mediators of systemic inflammatory response syndrome in the course of a severe delayed hemolytic transfusion reaction caused by anti-D. Transfusion 38:459–468
Vyas GN, Perkins HA, Fudenberg HH (1968) Anaphylactoid transfusion reactions associated with anti-IgA. Lancet 2:312–315
Walker DR, Branch DR, Dzik WH, Judd WJ, Kakaiya R, McMican A, Ness P, Polesky HF, Rolih SD, Vengelen-Tyler V (1993) Technical manual, 11th edn. American Association of Blood Banks, Bethesda
Wallace J (1977) Blood transfusion for clinicians. Churchill Livingstone, Edinburgh
Wang SE, Lara PN Jr, Lee-Ow A, Reed J, Wang LR, Palmer P, Tuscano JM, Richman CM, Beckett L, Wun T (2002) Acetaminophen and diphenhydramine as premedication for platelet transfusions:a prospective randomized double-blind placebo-controlled trial. Am J Hematol 70:191–194
Ward HN (1970) Pulmonary infiltrates associated with leukoagglutinin transfusion reactions. Ann Intern Med 73:689–694
Ward HN, Lipscomb TS, Cawley LP (1968) Pulmonary hypersensitivity reaction after blood transfusion. Arch Intern Med 122:362–366
Warkentin TE, Smith JW (1997) The alloimmune thrombocytopenic syndromes. Transfus Med Rev 11:296–307
Warkentin TE, Smith JW, Hayward CPM, Ali AM, Kelton JG (1992) Thrombocytopenia caused by passive transfusion of anti-glycoprotein Ia/IIa alloantibody (anti-HPA-5b). Blood 79:2480–2484
Watkins NA, Smethurst PA, Allen D, Smith GA, Ouwehand WH (2002) Platelet alphaIIbbeta3 recombinant autoantibodies from the B-cell repertoire of a post-transfusion purpura patient. Br J Haematol 116:677–685
Williamson LM, Lowe S, Love EM, Cohen H, Soldan K, McClelland DB, Skacel P, Barbara JA (1999) Serious hazards of transfusion (SHOT) initiative:analysis of the first two annual reports. BMJ 319:16–19
Win N, Peterkin MA, Watson WH (1995) The therapeutic value of HPA-1a negative platelet transfusion in post-transfusion purpura complicated by life threatening haemorrhage. Vox Sang 39:138–139
Yasukawa M, Shinozaki F, Hato T, Takada K, Ishii Y, Tamai T, Takamatsu H, Shinobara S, Yoshizaki K, Fujita S (1994) Successful treatment of transfusion-associated graft-versus-host disease. Br J Haematol 86:831–836
Zupanska B, Uhrynowska M, Guz K, Maslanka K, Brojer E, Czestynka M, Radomska I (2001) The risk of antibody formation against HNA 1a and HNA 1b granulocyte antigens during pregnancy and its relation to neonatal neutropenia. Transfus Med 11:377–382
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kiefel, V. (2010). Nichtinfektiöse unerwünschte Wirkungen. In: Kiefel, V., Mueller-Eckhardt, C. (eds) Transfusionsmedizin und Immunhämatologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-12765-6_37
Download citation
DOI: https://doi.org/10.1007/978-3-642-12765-6_37
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-12764-9
Online ISBN: 978-3-642-12765-6
eBook Packages: Medicine (German Language)